Everyone worries about fakes. In practice, for the grey market, the more common failure is a genuine molecule at 60% of the stated dose, or a vial with less powder than the label claims. It is not a counterfeit, it is a short measure, and it is much harder to notice because nothing looks wrong.
Which means the useful test is not “is this the right substance” but “is this the right amount”. Those are different questions with different methods and only the second one catches the thing that is actually happening.
Yes. And the tell is often behavioural: you need more of it than you used to, from a new batch. Which is also exactly what tolerance looks like, so people explain it away.
Confounding tolerance with underdosing is a genuinely under-discussed problem.
Same in tablets. A box that used to work and now does not, from the same seller, is more often a batch change than a tolerance change.